Expertise
Medical Cannabis: Therapeutic Utility and Risks  |  December 3, 2018

By Louis J Czaja, PharmD, BCGP As America’s opioid epidemic continues to escalate, the discussion surrounding legalizing medical marijuana has been widely considered as a means to combat it. Currently, marijuana is the most commonly used illicit drug in the United States, with 40 million people 12 years of age or older reporting use in…

Read More ›
axial takeaway: Pharmacy Quality Alliance Social Determinants of Health Forum  |  November 20, 2018

By Amber Watson, PharmD The World Health Organization defines social determinants of health (SDOH) as “the conditions in which people are born, grow, live, work, and age.” Examples of SDOH include economic stability, education, and social support. As the health system moves away from fee-for-service reimbursement and toward value-based care reimbursement, healthcare leaders are recognizing…

Read More ›
Recent Opioid Legislation: What it means for payers  |  June 28, 2018

For the past 18 months, the Trump Administration and Congress have been working feverishly to continue the fight against the nation’s opioid epidemic, and the House has spent the last several weeks discussing more than 50 bills, all of which focus on advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to…

Read More ›
Opioid, Pain & Chronic: How 3 Words Can Impact Our Solutions  |  December 21, 2017

In order to successfully offer clinicians and patients the highest quality pain care resources and tools, our solutions need to be informed by the latest evidence-based research. To do this, our data science and analytics team curates an extensive library of relevant literature, which is then used to define our methodology and inform capabilities like…

Read More ›
Substance Use Disorder and the Holidays  |  December 8, 2017

Although it should be a time of joy, many families will face tough situations this holiday season on account of a devastating drug epidemic   According to the Centers for Disease Control and Prevention (CDC), drug overdoses killed approximately 64,000 people in the US last year, rising more than 22% compared to 2015’s 52,404 recorded…

Read More ›
Misconceptions around Medication-Assisted Treatment: a Pharmacist’s View  |  May 24, 2017

Health and Human Services Secretary Tom Price’s recent comments regarding medication-assisted treatment (MAT) for the treatment of opioid use disorder (OUD) have received significant backlash from the healthcare community, prompting hundreds of healthcare and research professionals to sign a letter urging him to reconsider his statements. Price asserted that MAT involves substituting one addiction for…

Read More ›